Neoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response (MPR) rates ...

College of Chemistry and Materials Science, International Joint Laboratory on Resource Chemistry of Ministry Education, Shanghai Normal University, Shanghai 200234, P. R. China ...

Patients age 18 years or older from the United States and Canada with histologically confirmed stage IV or recurrent stage IIIB NSCLC per 7th International Association for the Study of Lung Cancer ...

ResultsThe median follow-up duration after surgical resection was four years ... neutrophil-to-lymphocyte ratio (NLR), Pulmonary carcinoid, Survival & prognosis, non-small cell lung cancer (NSCLC), ...

For appropriately staged non-small cell lung cancer (NSCLC) surgery is generally accepted as the most effective treatment, but some people may not be offered surgery because of concerns about ...

When lung cancer advances after initial lines of therapy, the treatment options dwindle. An AbbVie drug gives patients a new choice as the first FDA-approved treatment for advanced cases of non ...

May 14 (Reuters) - The U.S. Food and Drug Administration has approved AbbVie's (ABBV.N), opens new tab drug to treat adults with a type of lung cancer who have received previous treatment ...

May 13 (Reuters) - Britain's GSK (GSK.L), opens new tab and drug developer iTeos Therapeutics (ITOS.O), opens new tab said on Tuesday they have stopped developing an experimental lung cancer drug ...

A cancer patient who was ready to fly halfway across the country for a potentially life-saving double lung transplant has said he was denied insurance coverage at the last second. Married father ...

VATS is commonly used to perform both wedge resection and lobectomy. Studies have shown that people with lung cancer who undergo VATS consistently score higher in physical function, social function, ...